ü¿ÜÁø´Ü(IVD) ½ÃÀå : ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ - Á¦Ç°º°, °Ë»ç Àå¼Òº°, ÃÖÁ¾ ¿ëµµº°, ¿ëµµº°, ±â¼úº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End Use, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1679362
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 320 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,245,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,631,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,402,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ü¿ÜÁø´Ü(IVD) ½ÃÀå ¼ºÀå°ú µ¿Çâ :

¼¼°èÀÇ Ã¼¿ÜÁø´Ü(IVD) ½ÃÀå ±Ô¸ð´Â 2030³â¿¡´Â 1,501¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í, 2025³âºÎÅÍ 2030³â¿¡ °ÉÃÄ CAGR 5.62%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

³ëÀÎ Àα¸ Áõ°¡, COVID-19ÀÇ À¯Çà, Áø´ÜÀÇ ±â¼ú Áøº¸°¡ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. È޴뼺, Á¤È®¼º, ºñ¿ë È¿À²¼º Ãø¸é¿¡¼­ ±â¼ú Áøº¸´Â ¿µÇâ·ÂÀÌ Å« ·»´õ¸µ ÃËÁø ¿ä¼Ò Áß Çϳª·Î ¿¹ÃøµË´Ï´Ù. ±â¼úÀÇ Áøº¸´Â COVID-19ÀÇ Ã¼¿ÜÁø´ÜÁ¦ÀÇ ¹ß¸Å¿¡ ÀÇÇØ ´õ¿í °¡¼ÓµÇ¾î PCR°ú °°Àº ±â¼úÀ» À§ÇÑ ÀåÄ¡³ª ¼Ò¸ðǰÀÇ Ã¤¿ëÀ» °­È­Çß½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ °æÀï»çµéÀº Á¦Á¶¾÷ü¿Í »ç¿ëÀÚÀÇ ºñÁî´Ï½º È帧À» ÀÏÁ¤ÇÏ°Ô À¯ÁöÇϱâ À§ÇØ °è¾à ¹× ÆÄÆ®³Ê½Ê Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ °è¾àÀº ¶ÇÇÑ Á¤ºÎÀÇ ½ÇÇè½Ç¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡°Ý ¾ïÁ¦ Àü·«ÀÇ °á°úÀ̸ç, Á¤ºÎ ¼³Á¤ÀÇ °¡°ÝÀ» ³·Ãß°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 4¿ù, Seegene, Inc.ÀÇ ÀÌÅ»¸®¾Æ ÀÚȸ»ç´Â 715¸¸ °ÇÀÇ SARS-CoV-2 Áø´Ü Å×½ºÆ®»Ó¸¸ ¾Æ´Ï¶ó ÃßÃâ ½Ã¾à °ø±ÞÀ» À§ÇÑ °ø°ø Á¶´ÞÀ» À§ÇØ 1¾ï 825¸¸ ´Þ·¯ÀÇ ÀÔÂûÀ» ¹Þ¾Ò½À´Ï´Ù. SARS-CoV-2 Áø´Ü °Ë»ç´Â SARS-CoV-2 Áø´Ü °Ë»ç¿Í SARS-CoV-2 ÃßÃ⠽þàÀ» °ø±ÞÇÏ´Â °ÍÀÌ ÁÖ¿ä ¸ñÀûÀÌÁö¸¸ °ø±Þ¸ÁÀÇ ´ÙÀÚ°£ °Å·¡¿Í º¹À⼺ÀÌ Áõ°¡ÇÕ´Ï´Ù. ¾Ï°ú ½ÉÇ÷°üÁúȯ(CVDs)ÀÇ ¼¼°è À¯º´·üÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¶±âÁø´ÜÀ» ÃËÁøÇÏ°í ¼ÒºñÀÚÀÇ ²÷ÀÓ¾øÀÌ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇÑ Áø´Ü±â¼ú Çõ½ÅÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Plasmonic PCR°ú °°Àº »õ·Î¿î ±â¼úÀº ¿¹Ãø ±â°£ µ¿¾È »ó¾÷ÀûÀ¸·Î ½ÃÀå¿¡ ÁøÀÔÇÏ°í ±âÁ¸ Á¦Ç°ÀÇ ºñÁî´Ï½º¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ü¿ÜÁø´Ü(IVD) ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : º¯µ¿ ¿äÀΡ¤µ¿Ç⡤¹üÀ§

Á¦4Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : ±â¼úº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : °Ë»ç Àå¼Òº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå ü¿ÜÁø´Ü(IVD) ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦10Àå °æÀï ±¸µµ

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â